| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1005084360 |
| P356 | DOI | 10.1186/1746-1596-2-28 |
| P932 | PMC publication ID | 1971253 |
| P698 | PubMed publication ID | 17686142 |
| P5875 | ResearchGate publication ID | 6153659 |
| P50 | author | Cinthia B Drachenberg | Q88971263 |
| John C Papadimitriou | Q104508802 | ||
| P2093 | author name string | Borislav A Alexiev | |
| P2860 | cites work | Different patterns of chromogranin A and Leu-7 (CD57) expression in gastrointestinal carcinoids: immunohistochemical and confocal laser scanning microscopy study | Q28190126 |
| Siegfried Oberndorfer: origins and perspectives of carcinoid tumors | Q28300012 | ||
| Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. | Q34131025 | ||
| The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification | Q34321928 | ||
| Highlights of the biology of endocrine tumours of the gut and pancreas. | Q35624468 | ||
| Endocrine tumors of the gut and pancreas tumor biology and classification | Q35914978 | ||
| Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients | Q36006406 | ||
| Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract | Q36047418 | ||
| Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases | Q36059485 | ||
| Carcinoid of the ampulla of Vater | Q36107796 | ||
| Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor disease | Q40432966 | ||
| Risk of second cancers in patients with colorectal carcinoids | Q43670076 | ||
| Gastrointestinal carcinoid tumors: factors that predict outcome | Q44101477 | ||
| Molecular markers for reinforcement of histological subclassification of neuroendocrine lung tumors | Q47795731 | ||
| Pathological assessment of pancreatic endocrine tumors for metastatic potential and clinical prognosis. | Q53667553 | ||
| Valosin-containing protein (p97) and Ki-67 expression is a useful marker in detecting malignant behavior of pancreatic endocrine neoplasms. | Q54699679 | ||
| The incidence, management, and outcome of patients with gastrointestinal carcinoids and second primary malignancies | Q72161817 | ||
| The spectrum of neuroendocrine differentiation among gastrointestinal carcinoids: importance of histologic grading, MIB-1, p53, and bcl-2 immunoreactivity | Q73624230 | ||
| Carcinoid Tumors of the Gut | Q73671699 | ||
| Importance of proliferation markers in gastrointestinal carcinoid tumors: a clinicopathologic study | Q74233704 | ||
| Proliferative Activity in Pancreatic Endocrine Tumors: Association with Function, Metastases, and Survival | Q74453909 | ||
| The classification of carcinoid tum ours | Q76405787 | ||
| Familial carcinoid tumors and subsequent cancers: a nation-wide epidemiologic study from Sweden | Q77357641 | ||
| Immunohistochemical prognostic indicators of gastrointestinal carcinoid tumours | Q77742725 | ||
| Classification of low-grade neuroendocrine tumors of midgut and unknown origin | Q78582056 | ||
| Low nuclear proliferative activity is associated with nonmetastatic islet cell tumors | Q78870649 | ||
| The significance of CD44 expression in gastrointestinal neuroendocrine tumors | Q80343039 | ||
| Ki-67 immunoreactivity in the differential diagnosis of pulmonary neuroendocrine neoplasms in specimens with extensive crush artifact | Q81756755 | ||
| Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type | Q81880884 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreas | Q9618 |
| P304 | page(s) | 28 | |
| P577 | publication date | 2007-08-08 | |
| P1433 | published in | Diagnostic Pathology | Q18397261 |
| P1476 | title | Endocrine tumors of the gastrointestinal tract and pancreas: grading, tumor size and proliferation index do not predict malignant behavior | |
| P478 | volume | 2 |
| Q89736533 | Clinicopathologic analysis of primary gastroenteropancreatic poorly differentiated neuroendocrine carcinoma; A ten year retrospective study of 68 cases at Moffit Cancer Center |
| Q37605547 | Comparison of the prognostic values of the 2010 WHO classification, AJCC 7th edition, and ENETS classification of gastric neuroendocrine tumors |
| Q36326730 | Composite signet-ring cell/neuroendocrine carcinoma of the stomach with a metastatic neuroendocrine carcinoma component: a better prognosis entity |
| Q35976300 | Gastric GIST with synchronous neuroendocrine tumour of the pancreas in a patient without neurofibromatosis type 1. |
| Q37968479 | Neuroendocrine tumor of the pancreas in a patient with tuberous sclerosis: a case report and review of the literature. |
| Q37302846 | Predicting prognosis in gastroentero-pancreatic neuroendocrine tumors: an overview and the value of Ki-67 immunostaining |
| Q39880265 | Proliferative rate in endoscopic ultrasound fine-needle aspiration of pancreatic endocrine tumors: correlation with clinical behavior |
| Q36518549 | RUNX1T1: a novel predictor of liver metastasis in primary pancreatic endocrine neoplasms |
| Q37277702 | The relationship between lymphatic vascular density and vascular endothelial growth factor A (VEGF-A) expression with clinical-pathological features and survival in pancreatic adenocarcinomas |
Search more.